Monocyte-mediated antibody-dependent cell-mediated cytotoxicity: the role of the metabolic burst.
Human monocytes respond to opsonized microorganisms with a "metabolic burst" composed of an increase in oxygen consumption, an increase in hexose monophosphate shunt (HMPS) activity, and the generation of reactive oxygen species (ROS). We investigated the role of the metabolic burst in antibody-dependent cell-mediated cytotoxicity (ADCC) by human monocytes toward anti-D coated erythrocyte target cells because recent studies suggested a role for oxygen-dependent bactericidal mechanisms in ADCC. In normal monocytes, we found that ADCC was nearly halved under hypoxic conditions. Several agents known to impair activation of the burst, such as vincristine, cation chelators, and a sulfhydryl reagent, all decreased cytotoxicity if added before initiation of contact between target and effector cells. Cytotoxicity was inhibited by 2-deoxyglucose but not fluoride, suggesting a nonglycolytic role for glucose in ADCC, perhaps in the HMPS pathway. Although these data suggested a role for the metabolic burst in ADCC, scavengers of ROS did not impair cytotoxicity, and monocytes from chronic granulomatous disease (CGD) patients who had a defective metabolic burst had normal levels of ADCC. We conclude that ADCC toward anti-D coated erythrocyte target cells was the result of at least two independent but closely related cytotoxic pathways. Although one of these pathways appeared to involve the metabolic burst, the potentially cytotoxic reactive oxygen species did not appear to play a role in this system.
D000920:Antibody-Dependent Cell Cytotoxicity; D004492:Edetic Acid / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006105:Granulomatous Disease, Chronic / Q000276:immunology / Q000378:metabolism; D006600:Hexosephosphates / Q000378:metabolism; D006801:Humans; D000860:Hypoxia / Q000276:immunology; D009000:Monocytes / Q000276:immunology / Q000378:metabolism*; D009195:Peroxidase / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D006600:Hexosephosphates; D004533:Egtazic Acid; D014750:Vincristine; D004492:Edetic Acid; D009195:Peroxidase; D005947:Glucose; D005033:Ethylmaleimide